| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgements
|
|
|
|
32 |
S6 |
p. ix
|
artikel
|
| 2 |
CRUK
|
|
|
|
32 |
S6 |
p. vii
|
artikel
|
| 3 |
Editorial Board
|
|
|
|
32 |
S6 |
p. i
|
artikel
|
| 4 |
ESMO
|
|
|
|
32 |
S6 |
p. v
|
artikel
|
| 5 |
Journal Information
|
|
|
|
32 |
S6 |
p. ii
|
artikel
|
| 6 |
Molecular Analysis for Precision Oncology Virtual Congress 2021 Officers
|
|
|
|
32 |
S6 |
p. viii
|
artikel
|
| 7 |
1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation
|
Quintanal-Villalonga, Á.
|
|
|
32 |
S6 |
p. S1345
|
artikel
|
| 8 |
3MO Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
|
Marinelli, D.
|
|
|
32 |
S6 |
p. S1345-S1346
|
artikel
|
| 9 |
4MO p53 and p16ink4a as predictive and prognostic biomarkers for nodal metastasis and survival in a contemporary cohort of penile squamous cell carcinoma
|
Mishra, S.K.
|
|
|
32 |
S6 |
p. S1346
|
artikel
|
| 10 |
5MO Prognostic intra-tumoural heterogeneity in cancer-associated fibroblasts (CAFs) is linked to evolution of tumour from normal in pancreatic cancer
|
Hussain, A.
|
|
|
32 |
S6 |
p. S1346
|
artikel
|
| 11 |
2MO XPO1 inhibition strongly sensitizes to first-line and second-line therapy in small cell lung cancer
|
Quintanal-Villalonga, Á.
|
|
|
32 |
S6 |
p. S1345
|
artikel
|
| 12 |
51P A novel crosstalk between pyridoxal 5'-phosphate (PLP)-dependent enzymes, CBS and CSE, modulated by MALAT-1/STAT-3 axis
|
Khater, N.
|
|
|
32 |
S6 |
p. S1361
|
artikel
|
| 13 |
41P Attenuation of p53 signaling by CDK8/19 sensitizes tumor cells to ionizing radiation
|
Kuchur, O.A.
|
|
|
32 |
S6 |
p. S1358
|
artikel
|
| 14 |
59P Berberine chloride inhibits TNBC cell metastasis by downregulating expression of matrix metalloproteinases
|
Rajoriya, S.
|
|
|
32 |
S6 |
p. S1363-S1364
|
artikel
|
| 15 |
77P B7-H4 immune checkpoint protein as mediator of resistance to targeted therapy in renal cancer cells
|
Emaldi, M.
|
|
|
32 |
S6 |
p. S1369
|
artikel
|
| 16 |
76P B7-H3 immune checkpoint protein expression is associated with immune exhaustion, overall survival and metastasis in clear cell renal cell carcinoma
|
Nunes-Xavier, C.E.
|
|
|
32 |
S6 |
p. S1368
|
artikel
|
| 17 |
30P Bioinformatics analysis for lysyl oxidases as therapeutic targets for breast cancer
|
Ramos, S.
|
|
|
32 |
S6 |
p. S1355
|
artikel
|
| 18 |
29P Biological factors of breast cancer and DFS
|
Hussein, D.
|
|
|
32 |
S6 |
p. S1354
|
artikel
|
| 19 |
71P Breast cancer cells’ taxol-resistance is associated with cytoplasmic actin isoforms balance shift and acquisition of more malignant phenotype
|
Novikova, M.V.
|
|
|
32 |
S6 |
p. S1367
|
artikel
|
| 20 |
60P CCL2 expression and the neutrophil plasma membrane characteristics in blood in different stages of endometrial cancer
|
Abakumova, T.
|
|
|
32 |
S6 |
p. S1364
|
artikel
|
| 21 |
67P Challenges to molecular testing for selecting targeted therapies for oncology patients in India
|
Koyyala, V.P.B.
|
|
|
32 |
S6 |
p. S1366
|
artikel
|
| 22 |
61P Characterization of EMC2 gene as a potential prognostic marker of tumor diseases
|
Valsenkova, R.
|
|
|
32 |
S6 |
p. S1364
|
artikel
|
| 23 |
6P Circulating tumor DNA (ctDNA) next generation sequencing (NGS): Molecular prescreening for tailoring treatment in clinical trials
|
Alonso, G.
|
|
|
32 |
S6 |
p. S1346-S1348
|
artikel
|
| 24 |
10P Clinical and morphological pattern of malignant tumors with microsatellite instability (MSI)
|
Musaelyan, A.A.
|
|
|
32 |
S6 |
p. S1349
|
artikel
|
| 25 |
55P Clinical landscape of LAG-3-targeted therapy
|
Chocarro, L.
|
|
|
32 |
S6 |
p. S1362
|
artikel
|
| 26 |
58P Clinically actionable outcomes of next-generation gene sequencing test in advanced solid tumours in an Eastern Caribbean nation
|
Shanbhag, N.M.
|
|
|
32 |
S6 |
p. S1363
|
artikel
|
| 27 |
8P Clinical trial design in the era of precision oncology: An overview of the last 20 years
|
Filetti, M.
|
|
|
32 |
S6 |
p. S1348
|
artikel
|
| 28 |
78P Co-expression of CD44 and CD133 as cancer stem cells (CSC) markers in prostate cancer (PCa) tissue
|
Puchinskaya, M.
|
|
|
32 |
S6 |
p. S1369
|
artikel
|
| 29 |
47P Comprehensive molecular analysis of tissue samples from cancer patients: Evaluation of a novel all-in-one NGS strategy for diagnosis and theranostics
|
Dardare, J.
|
|
|
32 |
S6 |
p. S1360
|
artikel
|
| 30 |
56P Continuation treatment with immunotherapy beyond two years in patients with metastasic non-small cell lung cancer: Retrospective analysis of optimal duration treatment
|
Pellicer Boigues, A.V.
|
|
|
32 |
S6 |
p. S1362
|
artikel
|
| 31 |
82P Correlations of androgen receptor (AR) and transforming growth factor beta receptor type 2 (TGFbR2) expression in prostate cancer (PCa)
|
Puchinskaya, M.
|
|
|
32 |
S6 |
p. S1370
|
artikel
|
| 32 |
21P COVID-19 cancer patients and thromboembolic disease: Survival analysis
|
Pertejo-Fernandez, A.
|
|
|
32 |
S6 |
p. S1352
|
artikel
|
| 33 |
25P Early detection of breast cancer by liquid biopsy exploiting the DNA damage sensitivity (DDS)
|
Nussbaumer, R.
|
|
|
32 |
S6 |
p. S1353
|
artikel
|
| 34 |
46P Enhanced 5-aminolaevulinic acid (ALA)-based photodynamic therapy (PDT) efficacy by hormones in uterine sarcoma cells via upregulation of proporphyrinogen oxidase
|
Chu, E.S.M.
|
|
|
32 |
S6 |
p. S1359
|
artikel
|
| 35 |
45P Environmental scan of molecular profiling in Canada
|
El Bizri, M.
|
|
|
32 |
S6 |
p. S1359
|
artikel
|
| 36 |
16P Evaluation of the relationship between clinicopathological features at diagnosis and acquisition of T790M resistance mutation in patients with EGFR-mutant metastatic lung cancer
|
Dogan, I.
|
|
|
32 |
S6 |
p. S1350-S1351
|
artikel
|
| 37 |
74P Exosome profiling reveals prognostic markers of response to cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC)
|
Vardaki, I.
|
|
|
32 |
S6 |
p. S1368
|
artikel
|
| 38 |
53P Expression of sodium-dependent phosphate transporter NaPi2b is downregulated in malignant ovarian tumors after neoadjuvant chemotherapy
|
Nurgalieva, A.K.
|
|
|
32 |
S6 |
p. S1361-S1362
|
artikel
|
| 39 |
15P FGFR3-TACC3 fusion (F) as an acquired resistance mechanism following treatment with EGFR TKIs and a suggested novel target in aNSCLC
|
Ari, R.
|
|
|
32 |
S6 |
p. S1350
|
artikel
|
| 40 |
17P Genomic profiling of circulating tumour DNA in East Asian head and neck squamous cell carcinoma
|
Jia, N.
|
|
|
32 |
S6 |
p. S1351
|
artikel
|
| 41 |
22P Hepatocyte growth factor (HGF) and c-Met expression in metastatic endometrial cancer
|
Brieieva, O.
|
|
|
32 |
S6 |
p. S1352
|
artikel
|
| 42 |
80P HER2 expression in primary bladder tumors and paired regional lymph nodes: Relationship to cell cycle profile
|
Dumitru, M.
|
|
|
32 |
S6 |
p. S1369-S1370
|
artikel
|
| 43 |
69P HER2 status in RAS and BRAF wild-type metastatic colorectal cancer: Portuguese study
|
de Sousa, M.J.P.
|
|
|
32 |
S6 |
p. S1366
|
artikel
|
| 44 |
14P Identification of age-associated genes as prognostic factors in non-small cell lung cancer
|
Liu, J.
|
|
|
32 |
S6 |
p. S1350
|
artikel
|
| 45 |
54P Identification of patient-specific T-cell neoantigens through HLA-agnostic genetic screens
|
Scheper, W.
|
|
|
32 |
S6 |
p. S1362
|
artikel
|
| 46 |
49P Identifying and validating networks of oncology biomarkers mined from the scientific literature
|
Wager, K.
|
|
|
32 |
S6 |
p. S1360
|
artikel
|
| 47 |
32P Immunoregulatory loop between let-7a and CCAT1 lncRNA coordinated by c-Myc underlies the PD-1/PD-L1 immunoresistance in triple negative breast cancer patients
|
Selem, N.
|
|
|
32 |
S6 |
p. S1355
|
artikel
|
| 48 |
13P Incidental germline findings from tumor molecular profiling for precision oncology: Is it common and how to manage?
|
Ivanov, M.
|
|
|
32 |
S6 |
p. S1349-S1350
|
artikel
|
| 49 |
35P Increased sensitivity to olaparib by BRCA1/2 knockdown using a CRISPR/Cas9-mediated knock-in method in pancreatic cancer cell lines
|
Witz, A.
|
|
|
32 |
S6 |
p. S1356
|
artikel
|
| 50 |
63P Inhibition of AKT-signalling sensitizes A673 Ewing sarcoma cell line to doxorubicin
|
Galembikova, A.
|
|
|
32 |
S6 |
p. S1364-S1365
|
artikel
|
| 51 |
75P Karyopherin alpha 2-role in determining outcome for patients with bladder cancer: A systematic review and meta-analysis
|
Tan, A.O.
|
|
|
32 |
S6 |
p. S1368
|
artikel
|
| 52 |
9P Late phase I studies: Concepts and outcomes of a new clinical trial design
|
Benitez, J.C.
|
|
|
32 |
S6 |
p. S1348
|
artikel
|
| 53 |
70P Local features of germinal mutations incidence in cancer patients in the Republic of Bashkortostan
|
Sultanbaev, A.V.
|
|
|
32 |
S6 |
p. S1367
|
artikel
|
| 54 |
48P Low glucose sensitizes A431 skin cancer cells to metformin treatments: A way forward to targeting PD-L1
|
Mikhaylova, A.L.
|
|
|
32 |
S6 |
p. S1360
|
artikel
|
| 55 |
40P MALAT-1/miR-30a-5p competing endogenous (ceRNA) network releases the brakes of immune surveillance in breast cancer through its quadruple targets: PD-L1, MIF, IL-10 and TNF-α
|
Ramzy, A.
|
|
|
32 |
S6 |
p. S1357-S1358
|
artikel
|
| 56 |
42P Method optimization for the detection of chimerism by real-time PCR and droplet digital PCR
|
Lambrescu, I.M.
|
|
|
32 |
S6 |
p. S1358
|
artikel
|
| 57 |
52P MiRNA profile associated with the invasiveness in non-functioning pituitary adenomas
|
Nikolova, E.
|
|
|
32 |
S6 |
p. S1361
|
artikel
|
| 58 |
12P Molecular features of KRAS mutant NSCLC: Weaving a future score for immune-checkpoint inhibitors (ICI)
|
Dorta Suarez, M.
|
|
|
32 |
S6 |
p. S1349
|
artikel
|
| 59 |
68P Nuclear structures upon changes in the expression of cytoplasmic actin isoforms
|
Dugina, V.B.
|
|
|
32 |
S6 |
p. S1366
|
artikel
|
| 60 |
65P Oxidative stress associated with Cu2+ to Cu+ reduction for eradicating wild type and multidrug-resistant tumor cells
|
Tsymbal, S.
|
|
|
32 |
S6 |
p. S1365
|
artikel
|
| 61 |
57P Patients’ and caregivers’ perspective on biomarker testing across Canada
|
El Bizri, M.
|
|
|
32 |
S6 |
p. S1363
|
artikel
|
| 62 |
36P Plasma levels of hsa_circ_0001445 and hsa_circ_0007915 may indicate the presence of metastatic disease in patients with colorectal cancer
|
Radanova, M.
|
|
|
32 |
S6 |
p. S1356-S1357
|
artikel
|
| 63 |
18P Precision radiotherapy for centrally located non-small cell lung cancer (NSCLC)
|
Cheung, E.Y.W.
|
|
|
32 |
S6 |
p. S1351
|
artikel
|
| 64 |
7P Predictive and prognostic value of cell-free DNA in plasma and pleural lavage among surgically treated adenocarcinomas of the lung (ADCL)
|
Saikia, J.
|
|
|
32 |
S6 |
p. S1348
|
artikel
|
| 65 |
19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation
|
Dogan, I.
|
|
|
32 |
S6 |
p. S1351
|
artikel
|
| 66 |
37P Prognostic significance of immune checkpoint molecule expression in resectable gastric adenocarcinoma
|
Croitoru, V.M.
|
|
|
32 |
S6 |
p. S1357
|
artikel
|
| 67 |
38P Prognostic significance of karyopherin alpha 2 for patients with colorectal cancer: A review
|
Wijaya, J.H.
|
|
|
32 |
S6 |
p. S1357
|
artikel
|
| 68 |
39P Prognostic value of neutrophil-lymphocyte ratio in patients with advanced pancreatic cancer
|
Ben Kridis, W.
|
|
|
32 |
S6 |
p. S1357
|
artikel
|
| 69 |
33P Prognostic values of different subtypes of KRAS mutations in pancreatic cancer
|
Smirnov, S.
|
|
|
32 |
S6 |
p. S1355-S1356
|
artikel
|
| 70 |
62P Pyrrole-based carboxamides exhibit potent cytotoxic activities against epithelial cancer cell lines via targeting tubulin polymerization
|
Boichuk, S.V.
|
|
|
32 |
S6 |
p. S1364
|
artikel
|
| 71 |
11P ROS1-gene rearranged lung adenocarcinomas: Demographic, clinicopathologic and treatment profile in a cohort of Indian patients
|
Mishra, S.K.
|
|
|
32 |
S6 |
p. S1349
|
artikel
|
| 72 |
81P Safety and effectiveness of apalutamide for the treatment of non-metastatic castration-resistant prostate cancer (nm-CRPC): Preliminary results from an open-label expanded access protocol (EAP)
|
Campos-Gomez, S.
|
|
|
32 |
S6 |
p. S1370
|
artikel
|
| 73 |
27P Search for markers of breast carcinogenesis associated with ER status
|
Kalinina, T.
|
|
|
32 |
S6 |
p. S1354
|
artikel
|
| 74 |
73P Studying the immune microenvironment favouring initiation of invasion in cervical carcinoma
|
Kurmyshkina, O.V.
|
|
|
32 |
S6 |
p. S1367-S1368
|
artikel
|
| 75 |
31P Sulfhydryl groups in estrogen receptors
|
Burlaka, D.
|
|
|
32 |
S6 |
p. S1355
|
artikel
|
| 76 |
72P Targeting androgen receptor splice variant 7 in 22Rv1 prostate cancer cells
|
Scherbakov, A.M.
|
|
|
32 |
S6 |
p. S1367
|
artikel
|
| 77 |
66P TGF-β1: A crucial mediator of radioiodine therapy-induced anti-tumor immunity
|
Stanciu, A.E.
|
|
|
32 |
S6 |
p. S1365-S1366
|
artikel
|
| 78 |
24P TGF-βRI contributes to tamoxifen response in luminal B breast cancer with HER2-negative phenotype
|
Babyshkina, N.
|
|
|
32 |
S6 |
p. S1353
|
artikel
|
| 79 |
43P The effect of quercetin and doxorubicin treatment on the proliferative capacity of tumour cells
|
Diana, A.M.
|
|
|
32 |
S6 |
p. S1358-S1359
|
artikel
|
| 80 |
26P The multi-switching activity of circulatory neutrophils in patients with early breast cancer
|
Ramessur, A.
|
|
|
32 |
S6 |
p. S1353
|
artikel
|
| 81 |
79P The potential benefits of urinary and blood liquid biopsies for predicting early diagnosis, therapy response, and prognosis in renal cell carcinoma patients: A systematic review
|
Putra, B.P.
|
|
|
32 |
S6 |
p. S1369
|
artikel
|
| 82 |
20P Tissue agnostic application of mTOR inhibitors for the management of therapy-refractory solid tumors
|
Taghizadeh, H.
|
|
|
32 |
S6 |
p. S1352
|
artikel
|
| 83 |
50P Transcriptomic analysis of host immune response for precision drug prediction for SARS-CoV-2 infected patients: An evidence-based approach
|
Bohra, A.
|
|
|
32 |
S6 |
p. S1361
|
artikel
|
| 84 |
23P Transient multiple transfection of miR-181a into MCF-7 breast cancer cells induces irreversible resistance to tamoxifen
|
Andreeva, O.E.
|
|
|
32 |
S6 |
p. S1352-S1353
|
artikel
|
| 85 |
64P Tyrosine kinase signaling profile in osteosarcomas: A potential therapeutic target for sensitization to doxorubicin
|
Galembikova, A.
|
|
|
32 |
S6 |
p. S1365
|
artikel
|
| 86 |
34P Validation of a new scoring system for molecular subtyping of gastric cancer
|
Cazacu, I.M.
|
|
|
32 |
S6 |
p. S1356
|
artikel
|
| 87 |
28P Validation of cytokeratin (CK18) protein expression in epithelial cell lines and in circulating tumor cells (CTCs)
|
Raut, N.V.
|
|
|
32 |
S6 |
p. S1354
|
artikel
|
| 88 |
44P Value of comprehensive genomic profiling in pre-screening patients for NTRK fusion in STARTRK2 trial: Single centre experience
|
Ortega Franco, A.
|
|
|
32 |
S6 |
p. S1359
|
artikel
|
| 89 |
Table of Contents
|
|
|
|
32 |
S6 |
p. iv
|
artikel
|
| 90 |
83TiP Clinical implications of clonal hematopoiesis mutations in patients with solid tumors
|
Croitoru, V.M.
|
|
|
32 |
S6 |
p. S1370-S1371
|
artikel
|
| 91 |
84TiP Predictive value of exosomes for therapy response in resectable/borderline resectable pancreatic cancer patients
|
Cazacu, I.M.
|
|
|
32 |
S6 |
p. S1371
|
artikel
|
| 92 |
Title page and disclaimer
|
|
|
|
32 |
S6 |
p. iii
|
artikel
|
| 93 |
UNICANCER
|
|
|
|
32 |
S6 |
p. vi
|
artikel
|
Tijdschrift beschrijving